Bill Fawkner-Corbett, Head of SIGnet, takes us through his journey of discovering Compounders and the reasons for investing in them. He gives one example of a mistake he made selling Microsoft, which made him realise he had no effective tool for valuing Compounders. In his subsequent reading, he...
Published 03/27/24
Judges Scientfic CEO, David Cicurel, CFO, Brad Ormsby, COO, Mark Lavelle and Group Business Development Director, Tim Prestidge present results for the year ended 31 December 2023, followed by Q&A.
David Cicurel, CEO00:16 - Introduction05:26 - Acquisition strategy08:07 - FY23 highlights
Brad...
Published 03/27/24